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Abstract
Background: Interest in collecting Patient Reported Outcomes using electronic methods such as mobile phones
has increased in recent years. However there is debate about the level of measurement equivalence between the
traditional paper and newer electronic modes. Information about the acceptability of the electronic versions to
respondents is also required. The aim of this study is to compare the equivalence of delivering a widely used
generic measure of health status (EQ-5D-5L) across two administration modes (paper and mobile phone).
Methods: Respondents from a research cohort of people in South Yorkshire were identified, and randomly allocated
to one of two administration modes (paper vs. mobile phone) based on stratifications for age and gender (and across
a range of self-reported health conditions). A parallel group design was used where each respondent only completed
EQ-5D-5L using one of the modes. In total, 70 respondents completed the measure in the mobile phone arm, and 66
completed the standard paper version. Follow up usability questions were also included to assess the acceptability of
the mobile version of EQ-5D-5L. Measurement equivalence was compared at the dimension, utility score and visual
analogue scale level using chi square analysis and ANOVA, and by comparing mean differences to an estimated
minimally important difference value.
Results: Response rates were higher in the mobile arm. The mean EQ-5D-5L utility and VAS scores, and the
frequency of respondents endorsing individual EQ-5D-5L dimension response levels did not significantly differ
across the administration modes. The majority of the mobile arm agreed that the mobile version of EQ-5D-5L
was easy to complete, and that the phone was easy to use, and that they would complete mobile health
measures again.
Conclusions: Completing health status measures such as EQ-5D using mobile phones produces equivalent
results to more traditional methods, but with added benefits (for example lessening the burden of data entry).
Respondents are positive towards completing questionnaires using these methods. The results provide evidence
that electronic measures are valid for use to collect data in a range of settings including clinical trials, routine
care, and in health diary settings.
Background
The use of electronic methods such as laptops, tablets
and mobile phones to collect Patient Reported Outcome
Measure (PROM) or Clinical Outcome Assessment
(COA) data has increased substantially in recent years.
Technology advances and the increased prevalence of
electronic device ownership around the world [1] means
that electronic versions of COA (eCOA) can be used in
a wide range of areas including clinical trials, routine
health care and clinical settings, and also in the general
population as, for example, health diaries that enable the
assessment of change in health over time. Furthermore,
the potential for extending the use of eCOA given the
ongoing increase in the use of mobile devices is large.
Electronic methods can be useful for collecting sensi-
tive data, and reduce the burden of data entry which is
done automatically [2, 3]. They are also potentially more
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convenient to patients as they can be completed at a
time that suits them (and this can be recorded automat-
ically) which also has benefits in clinical settings where
data can be collected to inform consultations [4]. How-
ever paper versions have been seen as the ‘gold standard’
as the majority of existing COAs were developed and vali-
dated using this format. COAs may have to be adapted for
administration using electronic methods (for example by
changing the question layout or reducing the number of
questions per page), and subsequently there has been de-
bate about the level of measurement equivalence of data
collected using different administration modes. The most
recent Food and Drug Administration (FDA) guidance [5]
specifies that the measurement properties of eCOA used
to support labelling claims should be comparable across
modes. In a recent meta-analysis of the comparability of
electronic (via computer or PDA) and pencil and paper
COA administration, Gwaltney et al. [6] found extensive
evidence for equivalence across the modes. Other reviews
have also provided evidence for equivalence [7], but also
mixed results in terms of which produces the highest
quantity and quality of responses [8]. Bushnell et al. [9]
compared Personal Digital Assistant (PDA) and paper
administrations of EQ-5D in an irritable bowel syn-
drome population finding no mean difference between
the index scores and a high level of reliability across
the administrations.
As part of the process of validation of the new tech-
nology available, it is important that equivalence
between modes is demonstrated, and recommenda-
tions for research in this area have been published
[10]. It is also important to understand the usability of
the technology and the adapted measures. Work in-
vestigating the delivery of COAs using PDA’s is wide-
spread, and research investigating the administration
of COA using every day mobile devices such as smart-
phones and tablet computers is increasing. Extending
work in this area will support the development of, for
example, applications containing outcome measures
that could be downloaded onto an individual’s phone
or tablet and completed at a time suitable to them.
This has benefits for both clinical trials and the more
general use of health assessment tools amongst the
wider population.
This study aims to add to this literature by comparing
the administration of a widely used generic COA (the
EQ-5D-5L) between paper and mobile phone adminis-
tration modes. The primary objectives of the project are:
1. To investigate the equivalence of EQ-5D-5L data
collected using different modes of administration
(paper vs. mobile device with a touchscreen).
2. To examine the usability of the mobiles phones used
to collect data.
Methods
Measures and questions used
EQ-5D-5L
EQ-5D-5L [11] was used as the key outcome measure in
this study, with the administration of both the health
descriptive system and visual analogue scale (VAS) com-
pared across the modes. The EQ-5D-5L is an updated
version of the three level EQ-5D (EQ-5D-3L) [12], and
assesses health status across five dimensions (mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression) each with five response levels (none, slight,
moderate, severe and extreme/unable). The VAS assesses
self-reported health status on a 0 to 100 scale where 0 is
equivalent to worst imaginable health and 100 is equiva-
lent to the best imaginable health.
The EQ-5D-3L descriptive system has an associated
utility ‘value set’ based on the preferences of the general
population that allows the measure to be used in the
calculation of Quality Adjusted Life Years (QALYs) for
use in the economic evaluation of health interventions,
and is the measure accepted by reimbursement bodies
such as the United Kingdom National Institute of Health
and Care Excellence (NICE) and the Australian Pharma-
ceutical Benefits Advisory Committee (PBAC) for this
purpose [13]. The UK value set was developed using the
preference elicitation technique Time Trade Off (TTO),
and ranges from 1 (for the ‘best’ health state described
with no problems on each dimension (11111))–0.594 (for
the worse health state with extreme problems (33333)).
On this scale, 0 is equivalent to dead, and negative values
given to states perceived as worse than being dead (follow-
ing modelling of the TTO data) [14].
The EQ-5D-3L value set can be mapped onto EQ-5D-5L
health states where the best and worst health states are
anchored to the EQ-5D-3L utility scale [15]. This ‘cross-
walk’ value set is used in the analysis carried out in this
study and allows for an assessment of equivalence across
modes using a value set directly linked to the EQ-5D-3L.
EQ-5D-5L was used in this study as it is a widely used,
concise and validated generic COA that can be used both
with the general population and across patient groups.
Furthermore, the increasing use of EQ-5D-5L both in cost
effectiveness analysis (as part of trials and other studies),
population surveys and in routine healthcare settings
mean that it is an instrument that can be widely adminis-
tered using a range of administration modes. Therefore
evidence regarding equivalence across modes is important,
both for providing evidence for the use of the different
modes and equivalence of responses, and also for the use
of EQ-5D-5L.
The EQ-5D-5L and VAS were adapted for delivery via
mobile technology by the project team (see online sup-
plement 1), with the final version agreed by the EuroQol
Group (the EQ-5D-5L copyright holders). The paper
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version was matched with that recommended for use by
the EuroQol Group. In contrast to the paper version, it
is recommended that each of the five dimensions appear
on a separate page. Slight adaptations to the instructions
were made to reflect the fact that a touchscreen was
been used. The VAS was answered by pressing on the
relevant number on the scale, and the number automat-
ically appeared in the answer box, and could be changed
before proceeding. The paper VAS requires respondents
to fill in the relevant number in the available box. Each
question had to be answered before proceeding, and
respondents were able to scroll back to change their
answers during the completion of the survey, but not
once they had finished the questionnaire. Respondents
could stop during the completion of the EQ-5D-5L by
just exiting the application containing the measure on
the phone, but we could not record this information.
Due to the nature of the data collection process, ques-
tions on the paper version were not compulsory and
changes could be made at any time during the comple-
tion of the overall questionnaire.
Demographic and wellbeing questions
A range of demographic and health questions were col-
lected from all respondents using a paper questionnaire
(that was appended to the EQ-5D-5L for the paper arm,
and completed as a separate questionnaire following the
EQ-5D-5L for the mobile arm). This included questions
about age, gender, marital status, education, and long
standing health conditions. The four subjective wellbeing
and satisfaction questions used by the Office of National
Statistics (ONS) as part of the household survey [16]
were also collected, with the addition of an extra ques-
tion. The questions examined health satisfaction, life sat-
isfaction, happiness and anxiety yesterday, and whether
life is perceived as worthwhile on a 10 point scale from
‘not at all’ (0) to ‘completely’ (10).
Usability questions
Questions investigating the usability and acceptability of
the mobile phones were also included. These investigated
whether respondents would use phones to complete COAs
again, whether the questionnaire was easy to complete and
read, whether the touchscreen could be used, and also the
usability of the questionnaire (see online supplement 2).
Paper arm respondents were asked whether they would
complete COAs such as EQ-5D-5L using a mobile phone.
Study design
In this study a parallel groups design was used, with
respondents randomly allocated to either the mobile
(n = 100) or paper (n = 100) completion arm. The paper
questionnaire and mobile device (if relevant) were then
sent to the respondents. Detailed instructions about
how to access the mobile questionnaire, and the order
in which the questions should be completed, were in-
cluded. After completion, respondents were asked to
return the questionnaire and mobile device to the study
team using a freepost envelope provided. If there was no
response, or if the mobile questionnaire was completed
but the device was not returned, then a follow up email (if
possible) or letter was sent. This procedure was approved
by the School of Health and Related Research, University
of Sheffield, ethics committee.
Sampling and recruitment
Participants in this study were recruited from the Yorkshire
Health Study (YHS) [17] between February and September
2014. The YHS is a large scale longitudinal study collecting
information over two waves about the health of residents in
Yorkshire and Humberside areas of the United Kingdom.
The first wave contains records for 27,806 individuals
(2010–12), aged between 16 and 85 from South Yorkshire.
As part of the survey, respondents are asked to indicate
whether they are willing to take part in further research
projects, and respondents in this study were identified from
those aged over 18 who agreed to be contacted. Eligible
respondents were identified and stratified across five age
groups (18–30; 31–40; 41–50; 51–60 and 60+) and gender.
A random sample of 200 respondents across the age groups
and who self-reported a range of health conditions was
then selected and randomly allocated to each arm.
Analysis
The aim of the analysis was to assess the acceptability and
usability of the mobile EQ-5D-5L, and compare the scores
produced across different samples, in line with the recom-
mendations of Coons and colleagues [10] for comparing
COA equivalence. Proportion differences across the vari-
ous demographic indicators and EQ-5D responses were
tested using chi square analysis. ANOVA difference testing
was used to assess the equivalence of EQ-5D-5L utility and
VAS scores across the arms. The magnitude of the mean
difference between the utility and VAS scores was also
assessed in comparison to an estimated value for the min-
imally important difference (MID) of the EQ-5D-5L. The
estimate was calculated from the study sample, as currently
no estimate of the MID if EQ-5D-5L in the general popula-
tion using the crosswalk tariff is available. The value range
for the MID was calculated by multiplying the pooled
standard deviation of the EQ-5D-5L utility and VAS scores
by 0.2 (to estimate the lower bound) and 0.49 (to estimate
the upper bound). This following Cohen’s effect size guide-
lines [18], where a small effect size between 0.2 SD and
0.49 SD may represent a MID range, and mean differences
between arms at or below this range suggests equivalence.
Linear regression was used to assess whether the study
arm and a range of background characteristics significantly
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impacted on EQ-5D-5L utility score (while holding the
other indicators included in the model constant). This took
the form:
y ¼ Xβþ ε
where y is the utility value, X represents the explanatory
sociodemographic variables, and ϵ represents the error
term capturing other factors. For each of the utility esti-
mations and the VAS, three models were estimated:
study arm and socio-demographic variables (models 1, 4
and 7); study arm and self-reported health variables
(models 2, 5 and 8); study arm, demographics and self-
reported health variables (models 3, 6 and 9).
EQ-5D-3L data from the respondent’s completion of
the first wave YHS questionnaire (between June 2010
and April 2011) were used to compare health differences
amongst those who did or did not respond. Differences
in scores across the time points were also compared.
Results
Response rates
In total, 97 mobile arm and 100 paper arm packs were sent
out, with a completion rate of 73 % and 66 % respectively
(see Table 1). In the mobile arm, eight respondents returned
the phone indicating that they did not consent to take part,
and six returned the phone indicating that they had an
issue sending the data after completing the EQ-5D-5L. This
means that the mobile arm response rate (including com-
pleters and those non-consenting or having data sending
issues is 87 %). Overall, 12 mobile arm respondents did not
complete the EQ-5D-5L or return the phone. One respond-
ent in the mobile arm completed the EQ-5D-5L but did
not return the paper questionnaire. In the paper arm, 34
respondents did not complete or return a questionnaire.
The demographics and usability results reported here are
based on a sample size of 70 for the mobile arm and 66 for
the paper arm.
Demographics
Table 2 displays the demographic characteristics of the two
samples. The samples do not significantly differ across any
of the characteristics measured. Younger people (aged up
to 30) are underrepresented in the sample, with an equal
split across the genders. A large majority of the sample are
employed and responders are generally well educated (with
slightly under half reporting having a university degree or
equivalent). Just under half of the sample report at least
one long term condition, with a maximum of seven re-
ported. The most common conditions were tiredness
(27.9 %), high blood pressure (11.0 %), arthritis (9.5 %),
pain (14.0 %) and breathing problems (13.2 %). Overall,
respondents reported high levels of health and life
satisfaction and feeling worthwhile, a high prevalence
of feeling happy, and a low prevalence of feeling anxious
(see Fig. 1) with no differences across the arms. The
majority of the sample across both arms reported owning a
smartphone. In comparison to the first wave YHS data,
non-responders report significantly better EQ-5D-3L scores
than responders (0.945 vs. 0.896; F(1,191) = 4.25, p = 0.04).
Usability of mobile device
Respondents were positive towards the mobile EQ-
5D-5L questionnaire. Overall, 85.5 % agreed that they
would complete a questionnaire using a mobile again;
80.0 % agreed that the questionnaire was easy to
complete; 88.4 % agreed that the questionnaire could
be read on the screen; 85.5 % agreed that they could
use the touchscreen; and 87.0 % agreed that the phone
Table 1 Response rates across the arms
Mobile (n,%) Paper (n,%)
Responder 71 (73.2) 66 (66.0)
Non consent 8 (8.2) n/a
Data sending issue 6 (6.2) n/a
Non-responder 12 (12.4) 34 (34.0)
Table 2 Background characteristics of the two samples
Mobile (n = 70) Paper (n = 66) Significance
Age
Mean (SD) 44.5 (12.0) 46.2 (13.3) 0.424
Range 20-64 20-65
18-30 10 (14.5) 12 (18.2) 0.460
31-50 33 (47.8) 25 (37.9)
50+ 25 (36.2) 29 (43.9)
Male 34 (48.5) 33 (50.0) 0.868
Marital
Married/partner 42 (60.0) 42 (63.6) 0.896
Single 17 (24.3) 14 (21.2)
Other 11 (15.7) 10 (15.2)
Employment
Employed 52 (74.3) 53 (80.3) 0.817
Student 4 (5.7) 2 (3.0)
Retired 6 (8.6) 5 (7.6)
Not in employment 8 (11.4) 6 (9.1)
Education past min age 56 (80.0) 46 (70.0) 0.166
Degree 32 (45.7) 32 (48.5) 0.746
Long term condition 32 (45.7) 32 (48.5) 0.883
Number of LTCs 0.417
0 38 (54.3) 34 (51.5)
1 17 (24.3) 22 (33.3)
2+ 15 (21.4) 10 (15.2)
Own smartphone 54 (77.1) 48 (72.7) 0.552
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was easy to use, simple and clear to understand. Six
respondents (all aged over 30) disagreed with all five
usability questions, with five of this group owning a
smartphone.
Acceptability of using mobile phones (pencil and paper
arm)
In total, 47 respondents in the paper and pencil arm
owned a smartphone, with 30 (64 %) indicating that they
would use a smartphone to complete questionnaires
such as EQ-5D-5L. Of the 18 who did not own a smart-
phone, six (28 %) reported that they would use phones
to complete health questionnaires. Of the 30 respon-
dents who indicated that they would not use a phone to
complete a questionnaire, 17 (57 %) were aged over 50
with 11 (37 %) aged between 30 and 50, meaning youn-
ger people are more positive towards the use of mobile
phones to complete questionnaires than older people.
Measurement equivalence
EQ-5D-5L comparisons across modes
The frequency of respondents endorsing the EQ-5D-5L
categories across each of the dimensions does not sig-
nificantly differ across the modes (Table 3), and there
was no missing data across the arms.
EQ-5D-5L utility comparisons
Figure 2 displays the overall distribution of the EQ-5D-5L
utilities estimated using the crosswalk value set [15] . The
data is bi modal (which is an artefact of the nature of the
EQ-5D-3L UK value set developed by Dolan [14]) and posi-
tively skewed. There is also evidence of a ceiling effect (with
a substantial proportion of the sample reporting the ‘best’
health state), a common finding in EQ-5D data [19], with
less of a ceiling effect in the mobile arm (24 vs. 36 %). The
most commonly occurring states were 11111 (30.1 %),
11121 (slight pain or discomfort; 23.5 %), and 11112 (slight
anxiety or depression; 9.6 %). That the percentage reporting
slight pain or discomfort is generally quite high may
demonstrate the increased sensitivity of the EQ-5D-5L
descriptive system for this dimension (in comparison to
EQ-5D-3L).
The mean EQ-5D-5L utility scores are 0.797 for the mo-
bile arm (range 0.028–1, median 0.837) and 0.845 for the
paper arm (range 0.193 to 1, median 0.837). These values
are not significantly different (F(1,133) = 2.09, p = 0.15). The
mean difference between the utility scores is 0.048, and this
is just within the lower bound of the estimated MID range
(0.047–0.115). Therefore there is the suggestion that the
values are equivalent, but the results relating to the MID
need to be interpreted with caution due to the instability of
the MID estimates carried out on a small sample size.
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The mean EQ-5D-5L VAS scores were 80 (Mobile:
range 16–100; median 85) and 83 (Paper: range 30–
100; median 85) which were not significantly different
(F(1,133) = 0.68, p = 0.41). The mean difference between
the VAS scores is approximately 3, and this is below
the lower bound of the estimated MID range (3.5–7.9).
Comparing the paper based original EQ-5D-3L scores
from the first YHS wave and the EQ-5D-5L scores from
this study demonstrates that correlations between the
scores are higher in the paper arm (0.85) than the
mobile arm (0.52), but this is difficult to interpret given
differences in the descriptive system used and the length
of time between administrations.
Table 4 reports regression analysis of the impact of study
arm, a range of background variables and self-reported
health status on EQ-5D-5L scores. The models suggest that
the EQ-5D-5L utility scores are not significantly impacted
by study arm, holding demographic characteristics (Models
1 and 4) and self-reported health variables (models 2 and 5)
constant. Study arm approaches significance when included
in a model with background characteristics to a greater
extent than when regressed with self-reported health
variables. Model 2 suggests that having a long term
condition and low health satisfaction are explanatory
factors of EQ-5D score. The study arm does also not
impact on VAS score.
Discussion
The results of this study suggest measurement equivalence
for EQ-5D-5L when administered across different modes
of administration. We found suggested evidence for
equivalence of EQ-5D-5L scores across the modes using
analysis recommended to test COA equivalence [10], and
the findings are in line with past research, not only using
EQ-5D [9] but a range of other measures [6, 8, 20].
Coupled with the positive opinions of respondents towards
the usability of the mobile phone and the higher response
rates, the results lend support to the use of mobile technol-
ogy to collect data given the advantages of this mode relat-
ing to automatic data entry and the increased convenience
of flexible completion. We found that older people who
were not exposed to using the mobile device were less in-
clined to say that they would use one, and this is an area
where it is important to target in terms of possibly increas-
ing response rates.
In this study a parallel groups design was used to com-
pare the equivalence of the EQ-5D-5L across administra-
tion modes. In COA equivalence research, the most
widely used methodology in recent is the crossover design,
where respondents complete measures using both admin-
istration modes [21, 22], and it may be more efficient (and
Table 3 Frequency of responses across the EQ-5D-5L dimensions
Dimension/level Mobile Paper Significance
Mobility 0.10
None 49 57
Slight 11 5
Moderate 9 4
Severe 0 0
Unable 0 0
Self-care 0.05
None 62 65
Slight 6 0
Moderate 1 1
Severe 0 0
Unable 0 0
Usual activities 0.26
None 54 58
Slight 9 6
Moderate 6 2
Severe 0 0
Unable 0 0
Pain/discomfort 0.45
None 26 31
Slight 34 29
Moderate 4 5
Severe 4 1
Extreme 1 0
Anxiety/depression 0.88
None 43 44
Slight 20 17
Moderate 4 4
Severe 1 0
Extreme 1 1
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allow for more detailed follow up and usability questions)
if this method was used. However using a crossover design
was not possible logistically given the methodology used
to collect data that involved sending out study materials
by post to respondents and asking them the return the
completed materials to the study team. This is difficult, as
there are many confounding factors relating to the length
of time taken to return the first set of materials and then
the time taken for the respondent to receive the second
set of materials that means that it would be difficult to
control experimental issues such as the time between
completions. This would limit the inferences that could be
drawn from the equivalence analysis carried out, as we
could not control for possible changes in health between
completions that could differ depending on differences in
the time taken to complete both study arms. Therefore a
parallel group design was used.
In the guidance paper outlining methods to test the
equivalence of COAs across models, a substantially
larger sample size per arm than was achieved in this
study is recommended (234 per arm). In this study a
smaller sample size was possible due to the time avail-
able for data collection, and the number of study packs
that we would need to be sent to gain a large enough
sample (around 700 based on the achieved response
rate). We recognise that this is a limitation of this
study, but believe that the results still provide an indi-
cation of equivalence of the EQ-5D which is a short
measure with standardised response options and is
therefore amenable to translation as an electronic form
and equivalence across administration modes.
There are a range of issues regarding the wider applic-
ability of the findings that need to be considered. Firstly,
younger people (who are generally smartphone owners and
technology literate) were underrepresented in the sample,
and this limits the representativeness of the sample and the
wide applicability of the findings. The sample was also
generally well educated and in employment which may not
represent those recruited to take part in trial, or complete
eCOAs in clinical settings. Secondly, respondents who
have indicated that they are interested in taking part in a
range of research studies were recruited, and this may not
reflect other samples (for example in trials) who may not
be used to the requirements of research or provide con-
sent. This may mean that the response rate is higher than
could be expected. Thirdly, we only required respondents
to complete the survey once rather than over time. This
means that we could not carry out test-retest reliability
analysis, or replicate the trial or health diary aspect of the
collection of eCOA that may be an important feature of
electronic data collection.
It is also possible that presenting the dimensions page by
page in the mobile phone version could influence the
results given that the respondent cannot see the full ques-
tionnaire in context. This is a general issue for testing
equivalence of COA data across modes where page by page
completion of electronic versions is recommended (as is
the case for EQ-5D-5L). However the results in this study
supporting equivalence across modes does not suggest that
the format difference was influential. Differences in format
could be examined using cognitive debriefing methods and
usability testing as suggested by Coons and colleagues [10].
Table 4 Regression analysis
Parameter EQ-5D-5L utility score (crosswalk) EQ-5D-5L utility score (Devlin et al) EQ-5D-5L VAS score
M1 M2 M3 M4 M5 M6: M7 M8 M9
Coef P Coef P Coef P Coef P Coef P Coef P Coef P Coef P Coef P
Study arm 0.07 0.05 0.03 0.24 0.03 0.14 0.04 0.05 0.02 0.29 0.02 0.17 3.13 0.27 −1.40 0.44 −0.65 0.69
Gender 0.01 0.75 −0.02 0.39 0.01 0.72 −0.02 0.35 2.09 0.48 −1.30 0.46
Age −0.00 0.11 −0.00 0.43 −0.00 0.14 0.00 0.43 −0.13 0.27 −0.06 0.40
Marital status −0.03 0.20 −0.01 0.70 −0.02 0.25 0.00 0.72 −0.86 0.67 1.02 0.38
Employment −0.02 0.34 0.01 0.26 −0.02 0.20 0.01 0.54 −2.22 0.13 0.17 0.84
Education > min 0.08 0.06 −0.00 0.94 −0.06 0.07 −0.04 0.84 6.19 0.08 −1.10 0.61
Degree −0.05 0.17 0.01 0.66 −0.04 0.18 0.01 0.50 −4.77 0.12 0.91 0.62
LT condition −0.05 0.06 −0.04 0.15 −0.03 0.14 −0.02 0.32 1.77 0.38 2.62 0.17
Health sat 0.06 0.00 0.06 0.00 0.05 0.00 0.05 0.00 6.66 0.00 7.14 0.00
Life Sat −0.00 0.80 0.01 0.50 0.01 0.25 0.00 0.87 −0.33 0.70 0.98 0.23
Happy −0.01 0.52 −0.01 0.56 −0.00 0.88 0.00 0.97 −0.88 0.29 −0.72 0.35
Anxious −0.01 0.13 −0.01 0.07 −0.00 0.09 −0.01 0.05 −0.08 0.81 −0.21 0.47
Worthwhile 0.02 0.00 0.01 0.10 0.02 0.00 0.01 0.07 1.99 0.00 0.89 0.14
N 128 129 127 128 129 127 128 129 127
R2 0.10 0.56 0.63 0.10 0.58 0.67 0.08 0.62 0.73
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The comparisons that we can make are also limited by
the amount of data that we could collect, and also it
would be interesting to collect data using a longer gen-
eric measures of HRQL such as the SF-12 [21, 22], or
other preference based measures such as the SF-6D [23].
The results of this study suggest a range of possible
further research studies. Firstly, we have shown equivalence
of a paper version with one standard mobile device, but it
would be interesting to compare usability across different
screen sizes and operating systems (and recent work by
Schick-Makaroff and Molzan [24] has shown the feasibility
of using iPads to assess quality of life). This is because if
COAs and other questionnaires are to be developed as apps
(and subsequently released via app stores), for desktops or
laptops, or developed for other modes such as smart televi-
sions, then equivalence and usability must be demonstrated
across a wide range of devices and screen sizes. This could
be done using the qualitative assessment of usability once
equivalence has been demonstrated [10], and this has been
done for a range of COA [25, 26].
The use of eCOAs is developing quickly and is increas-
ing in a range of settings including clinical trials, Bring
Your Own Device (BYOD) settings, and also in routine
clinical practice [4]. This study goes some way to support-
ing the use of EQ-5D-5L in these settings collected using
mobile phone technology. Given equivalence is demon-
strated, there is also the case for mixing modes to increase
response rates in populations who may not have high
levels of mobile phone literacy [27].
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